|
|
|
Volumn 28, Issue , 2014, Pages 30-38
|
|
Identification and management of toxicities from immune checkpoint-blocking drugs
a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;
IPILIMUMAB;
MONOCLONAL ANTIBODY;
NIVOLUMAB;
PEMBROLIZUMAB;
PROGRAMMED DEATH 1 LIGAND 1;
PROGRAMMED DEATH 1 RECEPTOR;
ANTAGONISTS AND INHIBITORS;
CHEMICALLY INDUCED;
DRUG ERUPTIONS;
DRUG-INDUCED LIVER INJURY;
ENTEROCOLITIS;
HUMAN;
ANTIBODIES, MONOCLONAL;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTIGENS, CD274;
CTLA-4 ANTIGEN;
DRUG ERUPTIONS;
DRUG-INDUCED LIVER INJURY;
ENTEROCOLITIS;
HUMANS;
PROGRAMMED CELL DEATH 1 RECEPTOR;
|
|
EID: 84925379870
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (54)
|
|
References (0)
|